32 results
424B3
INM
InMed Pharmaceuticals Inc
19 Oct 22
Prospectus supplement
6:10am
, global market development, mergers and acquisitions, licensing and corporate governance. During the period from 2011 to 2016, Mr. Adams served … and Corporate Governance Committee, satisfy the independence standards for those committees established by applicable SEC and Nasdaq rules.
EXECUTIVE
8-K
8cbc1fdyrk
10 Aug 22
InMed Announces Changes to its Board of Directors
8:12pm
424B3
x3ib0mx144n
6 Jul 22
Prospectus supplement
2:43pm
424B5
4mg227v 9jdvk40
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
mfh320gc lsv2122k
25 Apr 22
Prospectus supplement
5:02pm
424B3
0zi8 jsb8
7 Apr 22
Prospectus supplement
4:46pm
8-K
EX-10.1
yyubcvgue
22 Mar 22
Entry into a Material Definitive Agreement
6:05am
S-3
4fk3opmi788le 9m
4 Feb 22
Shelf registration
4:36pm
DEF 14A
0na2rhgnwo
28 Oct 21
Definitive proxy
3:07pm
10-K
138ks6 l0y
24 Sep 21
Annual report
7:31am